LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized Music Treatment for Alzheimer’s Disease | News

LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized Music Treatment for Alzheimer’s Disease | News

TORONTO–(Business enterprise WIRE)–Jun 2, 2022– 12.7 million People aged 65 and more mature are projected to have Alzheimer’s dementia by 2050. LUCID and JT are now partnering on the advancement of a prescription electronic therapeutic for Alzheimer’s sickness. Alzheimer’s is far more than just memory loss – neuropsychiatric signs and symptoms can consist of nervousness, […]